Skip to main content
. 2018 Apr 27;12(4):e0006442. doi: 10.1371/journal.pntd.0006442

Fig 2. Dose dependent immune responses to LPS in serum, ALS and fecal extracts.

Fig 2

[(A and B) geometric mean titers (95% confidence intervals) of antibody responses to LPS IgA in serum (A), IgG in serum (B) on the day before challenge (day 0) and on days 4, 7, 9, 28, and 84 following challenge with either 1x105 or 1x106 CFU doses of ETEC strain H10407. (C and D) geometric mean fold increase from day before challenge (95% confidence intervals), LPS IgA in ALS (C) on days 4, 7, 9, 28, and 84 and LPS IgA in fecal extracts (D) on days 4, 9, 28 and 84 following challenge. The titers are in log2 scale.].